Back
Vanguard S&P Small-Cap 600 Growth Index Fund ETF Vs. Oruka Therapeutics, Inc. Sector Stock Comparison
Buy
69
VIOG
Vanguard S&P Small-Cap 600 Growth Index Fund ETF
Last Price:
$125.17
Seasonality Move:
1.13%
Sell
40
ORKA
Oruka Therapeutics, Inc.
Last Price:
$31.98
Seasonality Move:
-10.99%
Buy
69
Vanguard S&P Small-Cap 600 Growth Index Fund ETF (VIOG)
is a Buy
Is Vanguard S&P Small-Cap 600 Growth Index Fund ETF a Buy, Sell or Hold?
-
The current Vanguard S&P Small-Cap 600 Growth Index Fund ETF [VIOG] share price is $125.39. The Score for VIOG is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
VIOG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Oruka Therapeutics, Inc. (ORKA)
is a Sell
Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VIOG Stock Price Chart
What is Vanguard S&P Small-Cap 600 Growth Index Fund ETF's stock price today?
-
The Vanguard S&P Small-Cap 600 Growth Index Fund ETF share price today is $125.39Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VIOG is experiencing slight buying pressure.
ORKA Stock Price Chart
What is Oruka Therapeutics, Inc.'s stock price today?
-
The Oruka Therapeutics, Inc. share price today is $31.97Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.
VIOG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 27.66 | Buy |
| Relative Strength Index (14 RSI): | 60.46 | Buy |
| Chaikin Money Flow: | 14346 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (118.59 - 125.47) | Buy |
| Bollinger Bands (100): | (117.88 - 123.46) | Buy |
ORKA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.74 | Buy |
| Relative Strength Index (14 RSI): | 61.53 | Buy |
| Chaikin Money Flow: | 394649 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.23 - 31.09) | Buy |
| Bollinger Bands (100): | (15.89 - 28.91) | Buy |
VIOG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 124.74 | Buy |
| 20-day SMA: | 123.57 | Buy |
| 50-day SMA: | 121.46 | Buy |
| 200-day SMA: | 115.1 | Buy |
| 8-day EMA: | 78.83 | Buy |
| 20-day EMA: | 40.97 | Buy |
| 50-day EMA: | 18.36 | Buy |
| 200-day EMA: | 4.87 | Buy |
ORKA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.97 | Buy |
| 20-day SMA: | 30.06 | Buy |
| 50-day SMA: | 28.52 | Buy |
| 200-day SMA: | 16.89 | Buy |
| 8-day EMA: | 30.34 | Buy |
| 20-day EMA: | 29.78 | Buy |
| 50-day EMA: | 27.54 | Buy |
| 200-day EMA: | 21.05 | Buy |
Vanguard S&P Small-Cap 600 Growth Index Fund ETF Earnings Growth & VIOG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.
Vanguard S&P Small-Cap 600 Growth Index Fund ETF Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Oruka Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||